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Inositol Phosphate Production in Aortic Vasculature of Rats During Pregnancy
Kirk P. Conrad,* Susan A. Barrera,* Peter A. Friedman,* and Vicki M. Schmidt*
*Departments ofPhysiology and *Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 037S6
Introduction
We postulated that vascular phosphoinositide metabolism is
attenuated during pregnancy, and thereby could contribute to
maternal vasodilation and reduced vascular reactivity. The ba-
sal rate of incorporation of '3Himyo-inositol and VHjglycerol
into phosphoinositides ofaortae from pregnant rats in vitro was
significantly reduced, when compared with vessels from virgin
animals. After injection of [Hjmyo-inositol intravenously into
chronically instrumented conscious pregnant and virgin rats,
the incorporation of the label by phosphatidylinositol was
66±4% less in aortae of gravid versus virgin animals (P
< 0.001), despite comparable plasma concentrations ofradioac-
tivity. Fold stimulation of total 13Hlinositol phosphates by argi-
nine vasopressin, norepinephrine, and angiotensin II over a 15-
min period was not different between aortic segments from vir-
gin and gravid rats, although both absolute basal and
stimulated levels were significantly less in vessels from preg-
nant animals. After 45 s of incubation with 10' M arginine
vasopressin, however, the fold-stimulation of VHlinositol tris-
plus tetrakisphosphate was reduced in aortae from gravid rats,
when compared with vessels from virgin animals (P < 0.005).
By HPLC, > 90% of the radioactivity in the 13Hlinositol tris-
plus tetrakisphosphate column fraction after 30 and 60 s of
agonist stimulation was VHlinositol-1,4,5-trisphosphate. We
further observed that the rate of uptake of [Hjmyo-inositol by
aortic vasculature obtained from gravid rats was significantly
(24%) less than uptake by vessels from virgin animals. Plasma
myo-inositol concentrations were not significantly different, but
presumably as a consequence of reduced uptake, aortic seg-
ments freshly isolated from pregnant rats contained 22±6%
less myo-inositol than vessels from virgin controls as measured
by gas chromatography-mass spectrometry (P < 0.03). We
conclude that myo-inositol uptake and content, phosphoinosi-
tide turnover, and inositol phosphate production are reduced in
aortic vasculature of gravid rats. (J. Clin. Invest. 1991.
87:1700-1709.) Key words: vasodilation * vascular reactivity .
norepinephrine* arginine vasopressin - angiotensin II - chroni-
cally instrumented conscious rats
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Vasodilation ofthe maternal circulation is a constant feature of
normal human pregnancy. Cardiac output, renal blood flow,
and glomerular filtration rate increase by 30 to 60% (1-3)
while blood pressure declines (4, 5). Furthermore, pressor re-
sponse to administration ofangiotensin II (6) and vascular reac-
tivity to infusion ofnorepinephrine (7) become attenuated. In-
sight into the mechanisms responsible for these phenomena
may be particularly critical because attenuation of vascular re-
sponses to angiotensin II and norepinephrine as well as sys-
temic and renal vasodilation are lost in women who develop
preeclampsia (6-9).
We have found that the chronically instrumented,
conscious rat manifests alterations in renal and cardiovascular
function during gestation, which are remarkably similar to
those observed in normal gravid women (10-13). Thus, the
pregnant rat may be a useful animal model in which to investi-
gate mechanism(s) responsible for maternal vasodilation and
attenuated vascular reactivity to vasoconstrictor hormones.
Since blood vessels of gravid rats (14-20), rabbits (21), cats
(21), and guinea pigs (22) demonstrate decreased vascular reac-
tivity in vitro or in situ, it seems likely that alterations within
the vasculature itself are important. Vasoconstrictor receptor
desensitization during pregnancy does not appear to account
for the refactory vascular response, at least to angiotensin II
and arginine vasopressin (23-26). (The density and affinity of
alpha,-adrenergic receptors on vascular smooth muscle have
not been evaluated during pregnancy.) Although controversial,
vasodilatory prostaglandins may not be involved in the vasodi-
lation and attenuated vascular reactivity of pregnancy either
(1 1, 22, 27). A possible role for cyclic guanosine-3',5'-mono-
phosphate and endothelium-derived relaxing factor has been
recently suggested (12, 28, 29). Alternatively, we postulated
that intracellular processes which mediate vasoconstriction
may be altered during gestation such that vasodilation and re-
duced vascular reactivity occur. As a first step, we examined
phosphoinositide turnover, an early event in the signal trans-
ducing pathway, which is critical to vascular smooth muscle
contraction (30, 31). The results support the view that phos-
phoinositide turnover, inositol phosphate production, and
myo-inositol uptake are significantly attenuated in aortic vascu-
lature of gravid rats. Similar changes in resistance vessels may
contribute to vasodilation or to reduced vascular reactivity
during pregnancy.
Methods
Long-Evans female rats of - 98 d of age were obtained from Charles
River Breeding Laboratories (North Wilmington, MA). They were
mated, and day 0 of gestation was documented by the presence of
spermatozoa in the vaginal lavage. (Rat gestation lasts 22 d.) Age-
matched virgin animals served as controls. Because we used biochemi-
cal procedures that involve short term labeling with the radioactive
precursor, ['H]myo-inositol and ['Hlglycerol, freshly isolated aortic tis-
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sue was used in order to obtain sufficient mass of vasculature to yield
detectable signals. On the day of study, agravid (gestational day 18-21)
and virgin rat were killed, and the aortae removed and placed in me-
dium (370C, pH 7.4) preequilibrated with 95% 02/5% CO2. After re-
moval of fat and branching vessels, the aortae were gently perfused to
remove residual blood. They were then cut into segments with a sharp
razor blade. The endothelium was not removed. The isolation proce-
dure lasted no more than 10 min.
Total water-soluble [3H]inositol phosphates. Aortic segments of
0.5-1.0cm in length were incubated at 370C in 1.5 ml Earle's Balanced
Salt Solution (EBSS)' +25 mM N-2-hydroxyethylpiperazine-N'-2-eth-
anesulfonic acid, pH 7.4, which contained 6 MCi/ml [3Hlmyo-inositol
(15 Ci/mmol; American Radiolabeled Chemicals, Inc., St. Louis, MO).
The medium was saturated with 95% 02/5% CO2 and fresh atmosphere
was introduced into the vials every 30 min. After incubation for 1, 2,3,
or 4 h, the tissues were washed with 2.0 ml ice-cold medium (X5). Next,
the aortic segments were incubated for 10 min at 370C in EBSS + 25
mM Hepes, pH 7.4, which contained 10 mM LiCi. LiCl was used to
inhibit breakdown of inositol phosphate(s), thus allowing for their ac-
cumulation (mainly inositol monophosphate) in order to facilitate de-
tection by scintillation counting. Agonist (norepinephrine, angiotensin
II, arginine vasopressin) or vehicle (0.9% saline or medium) was added
for a further 15-min incubation. Tissues were homogenized in 1.0 ml
0.6 N HCI04 (4°C). The homogenates were centrifuged at 3,200 g for
10 min and the supernatant neutralized with - 120 Ml 5.0 N KOH.
After another centrifugation step to pellet the KC104, the supernatant
was added to 9.0 ml 5 mM disodium tetraborate. The samples were
applied to anion exchange columns (32) (Dowex AG1-X8; Bio-Rad,
Richmond, CA). Myo-inositol and glycerophosphoinositol were eluted
with two to three successive applications of 10-12 ml each of 60 mM
sodium formate/5 mM disodium tetraborate. Total water-soluble
[3H]inositol phosphates (mainly inositol monophosphate) were eluted
at once with 12 ml 1.0 M ammonium formate/0.1 M formic acid.
Duplicate 500-microliter aliquots were counted in 10 ml scintillation
fluid (formula 963; New England Nuclear, Boston, MA) for 20 min
each (model LS 3801; Beckman Instruments, Inc., Wakefield, MA). In
preliminary experiments (n = 3), the 60 mM sodium formate/5 mM
disodium tetraborate effectively removed [3H]myo-inositol that failed
to come through in the sample void. This solution, however, did not
elute [3H]inositol-4-phosphate (< 0.3%), [3H]inositol-1,4-bisphosphate
(< 0.14%), or [3H]inositol-1,4,5-trisphosphate(< 0.14%). 1.0M ammo-
nium formate/0.1 M formic acid eluted 98.7% of [3H]inositol-1,4,5-
trisphosphate applied to the columns.
Separation of individual water-soluble [3H]inositol phosphates.
Aortic segments of0.5-1.0cm in length were incubated at 37°C in 1.5
ml EBSS + 20 mM Hepes, pH 7.4, which contained 10 MCi/ml [3H]-
myo-inositol. The medium was saturated with 95% 02/5% CO2 and
fresh atmosphere was introduced into the vials every 30 min. After
incubation for 3 h, the tissue was washed with 1.5 ml ice-cold medium
(x5). Aortic segments were then transferred to fresh medium at 37°C
(without LiCl), and vehicle or I07 M arginine vasopressin was added
for the indicated times (up to 2 min). Tissues were homogenized in 1.0
ml 0.6 N HCI04 (4°C) which contained phytic acid hydrolysate (- 26
Mg phosphorus) (33). The homogenates were centrifuged at 3,200 g for
10 min and the supernatant was neutralized with 1.25 ml freon/tri-n-
octylamine (1:1 vol/vol). After vortexing each sample for I min, the
phases were separated by centrifugation at 2,000g for 5 min. The upper
phase was then transferred to a graduated tube, and distilled water was
added to produce a final volume of 4 ml.
Individual water soluble inositol phosphates were separated by Ac-
cell QMA Sep-Pak column chromatography (Waters Associates, Mil-
ford, MA) (adapted and modified from reference 33). After application
of the sample to the Sep-Pak column, the following reagents were
pushed through (10 ml/min): distilled water (5 ml X 3), 5 mM Na2B4O7
(5 ml x 3), 0.05 M ammonium formate/0.005 M formic acid (5 ml
1. Abbreviations used in this paper: EBSS, Earl's balanced salt solution;
InsP, inositol phosphate; MI, myo-inositol.
x 2), 0.1 M ammonium formate/0.01 M formic acid (5 ml X 4), 0.4M
ammonium formate/0.04 M formic acid (3 ml X 4), and 1.0 M ammo-
nium formate/0. 1 M formic acid (5 ml X 4). All solutions, which con-
tained ammonium formate, were made by appropriately diluting the
stock solution, 1.0 M ammonium formate/0. 1 M formic acid, pH 4.75,
with distilled water. Duplicate 500-microliter samples from each frac-
tion were counted by liquid scintillation.
Validation studies using [3H] standards without (n = 3) and with (n
= 1 to 5) tissue were performed. The elution profiles were considerably
different from those published (33). For [3H]myo-inositol, 99.9% ofthe
standard was found in the void volume and in the initial water washes;
for [3H]inositol-4-monophosphate, 98.3% was eluted in the 0.05 M
ammonium formate fraction; for [3H]inositol- 1,4-bisphosphate, 95.6%
was eluted by 0.1 M ammonium formate; [3H]inositol-1,3,4-
trisphosphate, [3H]inositol-1,4,5-trisphosphate, and [3H]inositol-
1,3,4,5-tetrakisphosphate were all eluted by 0.4 M ammonium for-
mate, 97.5%, 97.5% and 98.7%, respectively. Comparable results were
obtained with tissue except that inexplicably, 12.2% ofthe [3H]inositol-
4-monophosphate came out early in the Na2B4O7 wash. All radioactive
standards were obtained from New England Nuclear, except for [3H]-
myo-inositol which was purchased from American Radiolabeled
Chemical, Inc.
HPLC was used to resolve the [3H]inositol phosphate (InsP)1,3,4 and[3H]InsP,,4,5 isomers as well as [3H]InsP1,3,4,5 in a few of the 0.4 M
ammonium formate fractions from the Sep-Pak columns (33). A
Rainin Dynamax HPLC (Rainin Instrument Co. Inc., Woburn, MA)
with dual pumps and a Partisil 10 z SAX column was used. The injec-
tate volume was 1.5-2.2 ml. The mobile phase consisted of a stock
solution of2 M ammonium formate/0. I M formic acid adjusted to pH
3.7 with orthophosphoric acid. The mobile phase was run at 1.25 ml/
min at a final concentration of 0.85 M ammonium formate for the
initial 18 min and then 1.80 M from 20 to 30 min. Collection of 18-s
fractions were made and counted by liquid scintillation. [3H]InsP,,3,4,[3H]InsP,,4,5, and [3H]InsP,,3,4,5 had retention times of5.0-6.3, 6.5-7.5,
and 20.0-21.8 min, respectively.
Phosphoinositides, in vitro labeling. Aortic segments of 1.0 cm in
length were incubated in 6 MCi/ml [3H]myo-inositol (0.47 MM) for 1, 2,
3, or 4 h as described above. They were then washed five times with 2.0
ml ice-cold medium, and homogenized in 2.0 ml chilled
CHC13:CH30H: concentrated HCI (200:100:1) and 0.4 ml distilled
water. After centrifugation at 1325 g for 5 min to separate the phases,
the lower chloroform layer which contained lipids was transferred to a
5.0-ml conical vial (Wheaton Instruments, Millville, NJ). The protein
was extracted again with fresh solvent. The lower phase was then com-
bined with the first and stored under N2 at -40°C. The following day,
after removal of a residual aqueous layer, the organic phase was dried
(Savant Speedvac Concentrator, Savant Instruments, Inc., Farming-
dale, NY or N-Evap; Organomation, South Berlin, MA). Unlabeled
phospholipid standards were added to the residue: 25 MAg phosphatidyl-
inositol-4,5-bisphosphate, 15 Mg lysophosphatidylinositol, 10 Mg phos-
phatidylinositol4-phosphate, and 10 MAg phosphatidylinositol (Sigma
Chemical Co., St. Louis, MO). The sides of the vials were washed with
an additional 0.5 ml of the acidified extraction mixture, and after dry-
ing, the residue was resuspended in 100 MI CHC13:CH3OH:H20-
37.5:12.5:1, and sonicated for 5 min (Branson Co., Shelton, CT). Thin
layer plates coated with Silica Gel H + 1% potassium oxalate (Analtec
Inc., Newark, DE) were activated for 30 min at 1 10°C. Samples were
applied in 1.0-cm lanes, and 50 Mul CHC13:CH30H:H20 was again
added to each vial, and then applied to the TLC plates. Lipids were
separated by a moving phase ofCHC13:CH30H:4 M NH40H 45:35:10
(34). The spots were visualized with iodine vapor, and after sublima-
tion, scraped into 10 ml scintillation fluid (formula 963; New England
Nuclear) and each counted for 20 min.
In several experiments, tissues were labeled with [3H]myo-inositol
in medium which contained concentrations of myo-inositol (Sigma
Chemical Co.) within the physiological range. That is, unlabeled myo-
inositol was added to the incubation medium to achieve a final concen-
tration of 50 MM. In some experiments Ham's F12:Eagles Minimum
Essential Medium (1:1; Hazelton Systems, Inc., Denver, PA) was used
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instead of EBSS. The myo-inositol concentration of this mixture was
55 gM.
Additional experiments were conducted using ['Higlycerol as a pre-
cursor (New England Nuclear). Aortic segments of 1.0 cm length were
incubated in EBSS + 20 mM Hepes, saturated with 95% 0215% CO2,
pH 7.4, which contained 50 MM myo-inositol (MI), 100 AM glycerol,
and 6 MCi/ml ['H]glycerol. Three aortic segments were used from each
animal. One ofthe segments was incubated for 1.5 h, a second segment
for 3.0 h, and a third also for 3.0 h. The third segment, however, was
also incubated with 1 MM norepinephrine during the last 1.5 h ofincu-
bation. The tissues were then thoroughly washed in ice-cold medium
(X5). Phospholipids were extracted and separated by TLC, and
counted as described above. Because phosphatidylinositol and phos-
phatidylserine comigrate in the TLC system previously described, they
were scraped from the plate, extracted from the gel, applied to another
TLC plate, and separated by a moving phase of CHCI3:CH3OH:CH3-
COOH:H2O (81:10:45:1) (35).
Phosphoinositides, in vivo labeling. Midpregnant and age-matched
virgin rats were chronically instrumented with a femoral venous cath-
eter using aseptic technique (1 1). 5-7 d later, the animals were adminis-
tered [3H]myo-inositol intravenously in a total volume of 250 Ml 0.9%
saline. Gravid and virgin rats received 43 MCi/275 g and 50 MCi/275 g
body weight, respectively. The catheter was then flushed with an addi-
tional 1.0 ml of0.9% saline. Blood (- 50 Ml) was drawn at 5, 15, 30, 60,
and 120 min after the injection of ['H]myo-inositol, and after centrifu-
gation the plasma was counted for radioactivity (10 Ml in duplicate). At
120 min, the rats were administered 40 mg/kg i.v. pentobarbital. A
laparotomy was quickly performed. The animal was killed by rapidly
withdrawing 10-20 cc of blood from the abdominal aorta. The aorta
was then removed and placed in ice-cold medium. It was next cleaned,
perfused, and cut into two 2.0-cm segments. These segments were thor-
oughly washed in ice-cold medium (X5), subjected to organic extrac-
tion, and the phospholipids separated by TLC and counted as de-
scribed above.
Myo-inositol uptake. Aortic segments were preincubated for 1 h in
EBSS + 20 mM Hepes, saturated with 95% 02/5% CO2, pH 7.4, in the
presence and absence of K+. To maintain constant osmolality, addi-
tional NaCl was added to the K+-free medium. The tissues were then
transferred to fresh medium, again with and without K+, which con-
tained 1 MCi/ml [3H]myo-inositol and 0.25 MCi/ml ['4Cjmannitol
(American Radiolabeled Chemical, Inc.). Unlabeled myo-inositol was
added to produce a final concentration of 35, 50, or 70 MM. After
incubations for 2, 5, 10, 20, 60, or 120 min, the tissues were vigorously,
but briefly washed in ice-cold medium and then homogenized in 1.0 ml
0.6 N HCI04. After centrifugation at 3,200 g for 10 min, the superna-
tants were neutralized with - 140 Ml 5.0 N KOH, and the KC104 was
removed by an additional centrifugation step. Radioactivity of the su-
pernatant was determined for ['H] and ['4C]. Corrections for efficiency
and channel crossovers were made. Extracellular ['H]myo-inositol was
subtracted from total to obtain intracellular ['H]myo-inositol. In an
additional experiment, 1 mM final concentration ofouabain was used,
instead of deleting K+ from the medium.
Plasma concentration ofmyoinositol, enzymatic-fluorometric assay
(adaptedand modifiedfrom references 36 and 37). 500 MA ofplasma was
chilled on ice and treated with 500 MI of ice-cold 0.6 N HC104 for 15
min. The mixture was vortexed every 5 min and the precipitated pro-
teins were pelleted by centrifugation. The supernatant was then treated
with 5.0 N KOH until the pH was 7.0. After another centrifugation
step, the volume was set to 1.0 ml by tare, and 200 Ml in triplicate was
assayed for MI, and an additional 200-Ml aliquot served as a blank. In
order to destroy endogenous glucose, 20 Ml of 0.1 N NaOH was added
and the samples were heated for 20 min at 75°C. After cooling to room
temperature, endogenous NADH was destroyed by addition of 20 Ml
1.6 N HCL. After a 10 min incubation, 1,600 M of50mM Na2CO3, pH
9.5, was added to each sample, followed by 200 Ml ofenzyme mixture.
The enzyme mixture was freshly prepared and consisted of 0.24% bo-
vine serum albumin, 0.5 U/ml myo-inositol dehydrogenase, and 6mM
NAD in 50mM Na2CO3 (all from Sigma Chemical Co.). For the blank,
BSA and NAD were added, but not myo-inositol dehydrogenase. Myo-
inositol standards were prepared in a final volume of200 Ml and ranged
from 0 to 12 nmol. Fluoroescence was read at 1 h by which time the
reaction had proceeded to completion. Excitation and emission wave-
lengths were 340 and 482 nm, respectively.
Gas chromatography-mass spectrometry (adapted and modified
from references 38 and 39). A 1.0-ml sample of chilled plasma was
treated with 1.0 ml ofice-cold 10% HC104 for 15 min. The mixture was
vortexed every 5 min and the precipitated proteins pelleted by centrifu-
gation. The supernatant was then treated with 5.0 N KOH until the pH
was 7.0. After another centrifugation step, the supernatant was trans-
ferred to a 5.0-ml Wheaton vial and 12,500 ng ofalpha-methyl-D-man-
nopyranoside was added as an internal standard (Aldrich Chemical
Co., Milwaukee, WI). The mixture was dried down in a savant Speed-
vac concentrator (2 h at 450C). The sides were then scraped with a
small metal spatula, and 250 M1 of trimethylsilating reagent was added
(4.25 ml pyridine, 500 Ml hexamethyldisilazane, and 250 /l trimeth-
ylchlorosilane; Aldrich Chemical Co.). After vortexing and sonication,
the samples were allowed to incubate for 1 h at room temperature
before a final centrifugation step. Standards containing 20, 50, and 100
ng/Ml of myo-inositol and of alpha-methyl-D-mannopyranoside were
run and yielded a linear relationship. A standard containing 50 ng/Ml of
myo-inositol and of alpha-methyl-D-mannopyranoside was processed
concurrently with each batch of four to six samples. In this way a
"relative response factor" of myo-inositol compared with the internal
standard could be calculated, and subsequently used to determine the
amount of myo-inositol in the sample. A Finnigan MAT (San Jose,
CA) 4000 gas chromatography-mass spectrometry (GC/MS) system
was used. The GC was a Finnigan model 9610 (Econocap SE-54 col-
umn, 30 meter X 0.25 mm inside diameter from Alltech Associates,
Inc., Avondale, PA). Electron-impact ionization was employed. The
sensitivity of the assay was 1 ng.
Aortic content ofMI. 2-cm segments of freshly isolated aorta were
thoroughly washed in ice-cold buffer free of myo-inositol. They were
then homogenized in 1.0 ml 0.6 N HC104 and the supernatant neutral-
ized with 5 N KOH. Myo-inositol content was measured by GC/MS as
previously described for plasma.
Analytical procedure. Aortic protein was determined by the tech-
nique of Lowry et al. (40) using bovine serum albumin (Sigma Chemi-
cal Co.) as a standard.
Statistical analysis. Two factor univariate analysis of variance was
used. Appropriate post-hoc tests, t tests and nonparametric tests were
applied as needed. P < 0.05 was taken to be significant.
Results
Total water-soluble [3HlIinositol phosphates. After various
times ofincubation with 3HMI, the basal accumulation oftotal
['H]inositol phosphates was significantly less in vasculature of
late gravid rats, when compared with that of virgin controls
(Fig. 1 and Table I). This finding held whether the data were
normalized to milligrams wet weight or protein. Hormone-sti-
mulated accumulation of ['H]inositol phosphates was also re-
duced in tissue from gravid animals (Table I). The ratio of
hormone-stimulated to basal production of ['H]inositol phos-
phates (fold stimulation) by aortic vasculature was not signifi-
cantly different between virgin and pregnant rats (Table II).
When various dosages of arginine vasopressin were tested
(10-9_10-6 M), the ratio ofstimulated to basal accumulation of
total ['H]inositol phosphates in aortic vasculature was consis-
tently similar between the two groups ofanimals (n = 6, virgin
and pregnant rats for each dose, data not shown).
Individual water-soluble [3Hlinositol phosphates. AVP
(l0` M) failed to stimulate production of ['H]inositol tris-
phosphate plus tetrakisphosphate at 45 s in aortic segments
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Figure 1. Time course of basal [3H]inositol phosphate production in
aortic segments obtained from virgin and pregnant rats (n = 7 animals
in each group). The tissues were loaded with [3H]myo-inositol for 1,
2, 3, or 4 h. For further details see Methods. Statistics were performed
by two-factor ANOVA; the P values given indicate that basal pro-
duction of total [3H]inositol phosphates was significantly less in tis-
sues from gravid rats when compared to that of virgin controls. Stan-
dard error bars are depicted in this figure and in all subsequent figures.
from 3 of 10 virgin and 2 of 10 pregnant rats. Thus, these
animals were omitted from the data portrayed in Fig. 2, A and
B. Note that for the remaining rats, the basal production of
[3H]inositol phosphates (time 0) was consistently less in aortic
segments from pregnant animals, as we observed in the study
oftotal water soluble [3H]inositol phosphates (Fig. and Table
I). After 45 s ofstimulation with AVP, the absolute production
of [3H]inositol phosphates was also less in vessels from gravid
rats (Fig. 2 A, P < 0.05 vs. virgin for [3H]inositol monophos-
phate and [3H]inositol bisphosphate). This finding is again con-
sistent with the study of total water-soluble [3H]inositol phos-
phates (Table I). However, the fold stimulation of [3H]inositol
phosphates by AVP was also reduced for aortae from pregnant
animals at the early time point of 45 s (Fig. 2 B; P < 0.005 vs.
virgin for [3Hlinositol monophosphate and for [3H]inositol
trisphosphate plus tetrakisphosphate).
Fig. 3 A portrays the separation of the standards [3H]-
InsP,,3,4 and [3H]InsP,,4,5 isomers as well as [3H]InsP,,3,4,5 by
HPLC. The 0.4-M ammonium formate fractions obtained
from the Sep-Pak columns were applied to the HPLC. Figure 3
B depicts representative HPLC profiles of [3H]inositol phos-
phates synthesized by an aortic segment obtained from a virgin
and pregnant rat. The vessels were stimulated with 10-7 M
AVP for 30 s. Table III summarizes all ofthe data obtained by
HPLC. At 30 and 60 s after addition of I0-' M arginine vaso-
pressin, [3H]InsP,,4,5 constituted > 90% of the total radioactiv-
ity in the 0.4 M ammonium formate fraction obtained from
the Sep-Pak columns for tissues from both virgin and pregnant
rats. Moreover, the absolute amount of [3H]InsP,,4,5 produced
by aortic segments from pregnant rats was consistently less
than that synthesized by tissues from virgin animals, although
in these experiments we did not measure basal levels.
Phosphoinositides, in vitro labeling. With a medium myo-
inositol concentration of 0.47 MM, incorporation of [3H]myo-
inositol into phosphoinositides of aortae obtained from rats at
day 19 of gestation was significantly less than observed in tis-
sues from virgin controls (Fig. 4, A-D). This finding was ob-
tained whether results were normalized to milligrams wet
weight or protein. The magnitude ofthe reduction in accumu-
lation of total [3H]inositol phosphates from aortae of gravid
rats discussed above (Fig. 1 and Table I) was comparable to the
relative decline in [3H]myo-inositol incorporation into aortic
phosphoinositides. Specifically, basal [3Hjinositol phosphate
production in vasculature ofgravid rats was 73.4±6.4% ofthat
produced by aortae from virgin rats, and incorporation of
[3H]myo-inositol into vascular phosphoinositides ofgravid an-
imals was similarly reduced after 3 h of incubation with the
label (phosphatidylinositol-4,5-bisphosphate, 62.8±5.4%;
phosphatidylinositol-4-phosphate, 57.7±8.3%; phosphatidyl-
inositol, 70.3±8.5%).
When myo-inositol concentration in the medium was ad-
justed to 50-55 ,M by adding unlabeled material, tissues from
late pregnant animals still incorporated less [3H]myo-inositol
than those ofvirgins (Table IV). Finally, the relatively deficient
uptake of [3H]myo-inositol into phosphoinositides of aortae
from gravid rats was observed whether the incubation medium
consisted of EBSS or Ham's Fl 2: Eagles Minimum Essential
Medium, 1:1 (Table IV).
Fig. 5, A and B depict incorporation of [3H]glycerol into
phosphatidylinositol and phosphatidylserine. In general, phos-
phatidylinositol incorporated considerably more label than
phosphatidylserine. Norepinephrine further stimulated uptake
into phosphatidylinositol, but not into phosphatidylserine.
Overall, aortic segments from gravid rats incorporated 19±5%
less [3H]glycerol into phosphatidylinositol than vessels from
virgin animals. On the other hand, uptake of the label into
phosphatidylserine was comparable in vasculature from gravid
and virgin rats.
Phosphoinositides, in vivo labeling. Dosages of [3H]myo-
inositol were administered intravenously, such that plasma ra-
dioactivity was not significantly different in pregnant and vir-
gin rats (Fig. 6 A). (Because endogenous plasma myo-inositol
concentration was not significantly different between gravid
Table I. Total [3H]Inositol Phosphate Production in Aortic Segments Obtainedfrom Virgin and Pregnant Rats*
Arginine
Basal Norepinephrine Basal vasopressin Basal Angiotensin II
P<O.OJ P<O.OJ P=NS
Virgin 1983±335 7877±760 2182±407 8402±1308 1735±319 2799±554
Pregnant 1513±81 5253±482 1031±112 4654±368 1247±67 1717±159
* Mean±SEM. Data are expressed as cpm/mg aortic protein. Six pregnant and six virgin rats were used. After two-factor ANOVA, Tukey tests
were employed. When basal levels were combined, a significant difference was obtained by the Mann-Whitney U Test (pregnant: 1,264±156
cpm/mg aortic protein; virgin: 1,966±815 cpm/mg aortic protein [P < 0.04]).
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Table IL Ratio of Vasoconstrictor to Basal Production
of Total [3H]Inositol Phosphates*
Fold stimulation by vasoconstrictors
Norepinephrine Arginine vasopressin Angiotensin II
Virgint 3.63±0.27 5.23±0.64 1.50±0.11
Pregnant 3.33±0.28 4.70±0.33 1.45±0.08
Virginlt 3.66±0.34 4.04±0.38 1.65±0.13
Pregnant 3.48±0.31 4.61±0.20 1.39±0.13
* Mean±SEM. The data from which these ratios were generated are
displayed in Table I. No significant differences were observed between
virgin and pregnant rats in the fold stimulation exerted by vasocon-
strictors. $ The original data were expressed as cpm/mg aortic wet
weight. 11 The original data were expressed as cpm/mg aortic protein
(see Table I).
and virgin rats, either (see below), the plasma specific activity
was also comparable.) Uptake of [3H]myo-inositol was only
detectable in lysophosphatidylinositol and phosphatidylinosi-
tol, the two most abundant phosphoinositides (Fig. 6 B). Com-
pared with aortic segments from virgin rats, those from gravid
animals incorporated 82±1 1% and 66±4% less label into lyso-
phosphatidylinositol and phosphatidylinositol, respectively.
Myo-inositol uptake. The rate of uptake of [3H]myo-
inositol by aortic vasculature from pregnant rats was 24% less
than [3H]myo-inositol uptake by vessels from virgin animals,
when medium myo-inositol was 50 ,gM (Fig. 7 A). Uptake of
[3H]myo-inositol was completely inhibited in vessels from both
virgin and pregnant rats by removing K+ from the medium
(Fig. 7 B) or by adding 1 mM ouabain (data not shown). More-
over, differences in uptake at 2 h were virtually abolished by
incubating vessels from pregnant and virgin rats (n = 5 each) in
70 and 35 M myo-inositol, respectively (data not shown).
Plasma concentration ofmyo-inositol. 1 ml of plasma was
obtained from three virgin and three late pregnant rats. Using
[3H]myo-inositol as a tracer, recoveries from the deproteiniza-
tion procedure were comparable between plasma samples from
pregnant and virgin animals and they averaged 62.6±2.7%. By
enzymatic-fluorometric analysis, plasma myo-inositol concen-
trations were 162±10 and 173±9 gM in virgin and pregnant
rats, respectively (n = 10 each). By GC/MS, values of87±8 and
96±6 AM were observed (n = 19 each). Plasma concentrations
of myo-inositol were not significantly different between virgin
and gravid rats by either method of measurement.
Aortic content ofmyo-inositol. Using GC/MS, the myo-ino-
sitol content of aortic segments from virgin (n = 9) and gravid
(n = 8) rats was 6.6±0.5 and 4.9±0.5 nmol/mg protein, respec-
tively (P < 0.03). Compared with vessels from virgin animals,
myo-inositol content was reduced by 22±6% in vessels from
gravid rats.
Discussion
Vasodilation of the maternal circulation and attenuation of
systemic pressor responsiveness are persistent features of nor-
mal human pregnancy. Chronically instrumented, conscious
rats also manifest these physiological alterations during preg-
nancy (10-13). Therefore, the gravid rat may be a useful ani-
mal model in which to investigate mechanisms responsible for
'P1
0 45 120
0 - Virgin
_ Gesutational day 19
IP3 + IP4
3-
2-
1-
0 -
3-
2-
1-
0 -
120
3-
0 45 120
2-
1-
0 -
3-
2-
1I
0-
0 45 120
Incubation time (seconds)
I4 Figure 2. Time course ofo 45 1207_stimulation by 107-M
arginine vasopressin of
individual water-soluble
[3Hjinositol phosphates
in aortic segments from
virgin (n = 7) and preg-
nant (n = 8) rats. See
Methods for details. IP,,
inositol monophosphate;
IP2, inositol bisphos-
phate; and IP3 + IP4,
inositol tris- plus tetrakis-
phosphate. *P < 0.05, **P
< 0.005 virgin vs. preg-
01 nant at the same time
point by unpaired t tests.
1704 K. P. Conrad, S. A. Barrera, P. A. Friedman, and V. M. Schmidt
A
3-
2-
I1-
10
0 -
aIxm ,.
g.O.
I!
0.
CL U.
_ aO E
aW
S EME
OL,
O-J
B
3-
0
0
c cC0
8 '
0 E
lb
I')
2-
0-
0 45
AFraction Number
B
Table III. HPLC Profile of[3H]Inositol Phosphate Synthesized
by Freshly Isolated Aortic Segments in Response
to 1t.7 MArginine Vasopressin
[3H]Inositol phosphate
Condition of
Rats Time(s) (1,3,4)IP3 (1,4,5)IP3 (1,3,4,5)IP4
cpm/mg aortic protein
Pregnant 30 4 176 4
Virgin 30 15 247 8
Pregnant 30 0 114 0
Virgin 30 37 242 0
Pregnant 60 0 105
Virgin 60 0 116 0
* These data were gathered from three different virgin and pregnant
rats. Aortic segments were labeled with 10 MCi/ml [3H]myo-inositol
for 3 h, incubated with 10-7 M AVP for 30 or 60s, extracted with
perchloric acid, and the water-soluble inositol phosphates then sepa-
rated by Sep-Pak chromatography. The inositol trisphosphate plus
tetrakisphosphate fraction was further separated by HPLC. See
Methods for details.
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Figure 3. Representative HPLC analyses of
synthesized by aortic segments in response to
pressin for 30 s. (A) A typical HPLC profile o
inositol phosphate standards applied to the c(
tative experiment in which the IP3 + IP4 frac
anion exchange columns were applied to the
details.
maternal vasodilation. Most (14-20), but
tors have demonstrated that the vascular
hibits attenuated reactivity to vasoconst
situ. Conduit vessels including the aorta (
as resistance vessels (17, 20) develop attez
ing gestation. Further, the affinity and de
sponsible for mediating the response to va
pregnancy have generally been reported X
26, 42). Vasodilatory prostaglandins ma
changes in vascular response to vasoconst
(1 1, 22). These studies were designed to ev
that alterations in postreceptor mechanisr
constriction, specifically of inositol lipid metabolism may ac-
count for vasodilation and reduced vascular reactivity that oc-
cur during pregnancy.
We first examined the production of total [3H]inositol
phosphates in the presence of 10 mM LiCl as an index ofphos-
phoinositide hydrolysis. Because basal production was altered
virgin in vessels from gravid animals (see below), hormone-stimu-
--* pregnant lated data were factored by basal values ("fold stimulation").
The fold stimulation by maximal doses of angiotensin II, argi-
nine vasopressin, and norepinephrine was not significantly dif-
ferent between aortae from gravid and virgin rats (Table II).
I_ ,* Moreover, the dose-response curves for arginine vasopressin
obtained in vessels from both groups of animals were similar
(see Results). These data suggest that activation of phospholi-
3'0 ' 4'0 * 5'0 pase C by vasoconstrictors is similar in aortae from pregnant
and virgin rats. However, insofar as these experiments were
imber conducted over a 15-min time period in the presence of LiCl,inositol monophosphate was probably the most abundant inosi-
[3H]inositol phosphates tol phosphate measured. Comparatively smaller changes in
0-' M arginine vaso- InsP,,4,5 produced at early time periods after addition ofagonist
f a mixture of [3H]- were therefore overlooked. Because InsP1,4,5 contributes to the
)lumn. (B) A represen- initial rise in intracellular calcium critical for development of
lions from the Seo-Pak smooth muscle contraction, we next measured this product
HPLC. See Methods for
within seconds to minutes following agonist stimulation. 45 s
after application ofarginine vasopressin (10-7M final concen-
tration), the fold stimulation of [3H]inositol tris- plus tetrakis-
not all (41) investiga- phosphate was significantly less in vessels from gravid rats (P
ture of gravid rats ex- < 0.005 vs. virgin; Fig. 2 B). Further separation of [3H]inositol
trictors in vitro or in tris- plus tetrakisphosphate by HPLC indicated that greater
14, 16, 19, 22), as well than 90% of the total radioactivity was in the form of InsP,,4,5
nuated reactivity dur- (Fig. 3 and Table III). With the caveat that a reduction ofradio-
mnsity of receptors re- active InsP,,4,5 does not necessarily imply a reduction in mass,
soconstrictors during the data suggest important biochemical differences are present
not to be altered (23- in aortic tissue of virgin and pregnant rats.
y not underlie these Basal accumulation of[3H]inositol phosphates was reduced
Aictor administration in aortae ofgravid rats (Fig. 1 and Table I). This finding could
raluate the hypothesis result from reduced labeling of phosphoinositides with [3H]-
ns that mediate vaso- myo-inositol (Fig. 4, A-D). Indeed, decreased labeling of the
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Figure 4. Time course of basal [3H~myo-inositol incorporation into
phosphoinositides of aortic segments obtained from virgin and gravid
rats (n = 9 animals in each group). The tissues were loaded for 1, 2, 3,
or 4 h with [3H]myo-inositol (6,Ci/ml). Only labeled myo-inositol
was added to the medium, so that the final concentration was 0.49
,uM. See Methods for details. Statistics were performed by two-factor
ANOVA; the P values given in the figures indicate that incorporation
of [3H]myo-inositol was significantly less in tissues from gravid rats
when compared with that of virgin controls.
phospholipids was uniformly observed, whether the medium
in which tissues were incubated contained 0.49 ,uM myo-inosi-
tol or a more physiologic concentration of50 uM, and whether
the medium used was a simple balanced salt solution or a cell-
culture mixture (Table IV). When in vivo labeling experiments
were performed in chronically instrumented conscious rats,
significant reductions in incorporation of [3H]myo-inositol
into phosphoinositides were again found in vessels from gravid
animals (Fig. 6).
Possible explanations for diminished labeling of aortic
phosphoinositides in gravid rats include: (a) attenuated cellular
uptake of [3H]myo-inositol, and (b) decreased turnover of
phosphoinositides. Decreased mass ofphosphoinositides could
also contribute to reduced [3H]myo-inositol incorporation. Be-
fore it can be incorporated into phosphoinositides, [3H]myo-
inositol must first be transported into cells. Our results suggest
that the mechanism of uptake in freshly isolated rat aorta is a
Na+-cotransport process, insofar as [3H]myo-inositol uptake
was completely inhibited in a K+-free medium or by 1 mM
ouabain (see Results and Fig. 7 B). A Na+-cotransport mecha-
nism for myo-inositol uptake has been reported for other tis-
sues (reviewed in reference 43). We further observed that the
rate of uptake of [3Hlmyo-inositol into vessels from gravid rats
was 24% less than uptake by vessels from virgin animals (Fig. 7
A). Although reduced cellular uptake of [3H]myo-inositol un-
doubtedly contributed to deficient labeling of phosphoinosi-
tides, this explanation alone cannot account for the diminished
labeling because the rate of incorporation of [3H]myo-inositol
into phosphoinositides was reduced by a greater extent, approx-
imately 50% (Fig. 4 and Table IV).
These results are compatible with the view that the turnover
of phosphoinositides is attenuated in aortae ofgravid rats. The
fact that, in addition to reduced incorporation of [3H]myo-
inositol, the uptake of [3H]glycerol into phosphatidylinositol
(Fig. 5 A; but not into phosphatidylserine, Fig. 5 B) was also
compromised, further supports the idea that phosphoinositide
turnover is attenuated in vessels from gravid rats. Compara-
tively less incorporation of [3H]glycerol persisted even when
uptake into phosphatidylinositol was stimulated by norepi-
nephrine (Fig. 5 A).
In aortic vasculature from gravid rats, it is possible that
reduced cellular uptake of myo-inositol limits the availability
of intracellular myo-inositol for optimal synthesis ofphospha-
tidylinositol. Consequently, basal as well as hormone-stimu-
Table IV. [H]Myo-inositol Incorporation into Phosphoinositides ofAortic Tissue*
Hours in [3H]myo-inositol ANOVA
cpm/mg aortic wet weight
1.0 2.0 3.0 4.0 Virgin vs. pregnant Time
rats (n)
Phosphatidylinositol Virgin (7) 51.6±14.0 147.7±27.2 203.7±23.2 303.6±59.1 P < 0.005 P < 0.001
Pregnant (7) 45.8±13.3 96.2±12.7 135.1±14.8 177.9±25.0
Lysophosphatidylinositol Virgin (7) 7.8±1.2 15.7±2.3 20.6±2.4 34.3±5.7 P < 0.001 P < 0.001
Pregnant (7) 6.1±1.6 8.7±1.7 13.1±1.6 21.7±2.6
Phosphatidylinositol-4- Virgin (7) 1.7±0.4 5.3±0.8 8.6±1.5 9.8±1.9 P < 0.01. P < 0.001
phosphate Pregnant (7) 1.3±0.2 4.3±0.3 5.9±0.9 6.0±0.9
Phosphatidylinositol-4,5- Virgin (7) 3.7±0.8 12.1±2.5 17.1±3.8 28.0±5.0 P = 0.13 P < 0.001
bisphosphate Pregnant (7) 3.6±0.8 7.7±1.3 13.1±2.6 23.3± 4.7
* Mean±SEM. Incubation media were Earle's Balanced Salt Solution (n = 4 rats) or Ham's F12: Eagles Minimal Essential Medium 1:1 (n = 3
rats) containing 50 and 55 gM myo-inositol, respectively. The results were similar and, therefore, combined. Pregnant rats were at day 20 of
gestation.
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Figure S. [3H]glycerol
25 incorporation into
-20 phosphatidylinositol
Is and phosphatidylserine
10 of aortic segments ob-
tained from virgin and
gravid rats (n = 9 rats
° in each group). Three
aortic segments were
used from each animal.
One of the segments
was incubated with 6
2.5 IACi/ml [3H]glycerol for
1.5 h, a second segment2.0 for 3.0 h, and a third
' 5 also for 3.0 h. The third
1.0 segment, however, was
.5 exposed to 1 gM nor-
0 epinephrine (NE) dur-
ing the last 1.5 h of in-
cubation. Medium con-
centrations of
myo-inositol and glyc-
erol were 50 and 100 uM, respectively. After loading of the aortic tis-
sues, they were thoroughly washed, and phospholipids were extracted
and separated by thin layer chromatography as described in Methods.
Statistics were performed by two-factor ANOVA; the P value given
in the figure indicates that overall, incorporation of [3H]glycerol into
phosphatidylinositol was significantly less in aortae from gravid rats
when compared with that in vessels from virgin controls.
lated turnover of phosphoinositides could be compromised.
Indeed, measurement of aortic myo-inositol content by GC/
MS demonstrated that vessels from pregnant rats contained
22±6% less myo-inositol (see Results). Because the Km for
myo-inositol CDP-diacylglycerol: inositol phosphatidyltrans-
ferase may be quite high, - 4.6 mM (43), any reduction of
intracellular myo-inositol could compromise synthesis of
phosphatidylinositol and, thus, ofpolyphosphoinositides. Inter-
estingly, the concept that reduced availability of myo-inositol
could compromise phosphatidylinositol biosynthesis has been
invoked to explain the change in phospholipid content of sur-
factant during lung maturation (44,45), the neuropathy ofdia-
betes (46), the salutory effect of Li' in affective disorders (47,
48), as well as the accumulation of triacylglycerol in liver and
intestinal lipodystrophy which occur with deficiency ofdietary
inositol (reviewed in reference 43).
The mechanism of reduced myo-inositol uptake by aortic
vasculature ofgravid rats is unknown. We considered the possi-
bility that elevated plasma levels could downregulate the trans-
porter. However, two independent methods of measurement
failed to reveal significant differences in plasma myo-inositol
concentrations between virgin and pregnant rats (see Results).
In addition to alterations ofthe Km or V.. ofthe Na/myo-ino-
sitol cotransporter, differences in Na/K ATPase activity could
be responsible. Indeed, increased levels of circulating digitalis-
like natriuretic factor have been reported in pregnancy (49). It
would be of interest to determine if the defect in myo-inositol
uptake that we observed is specific to vasculature, and whether
other substances that undergo Na'-cotransport are also af-
fected.
In summary, we have acquired evidence for attenuation of
myo-inositol uptake, phosphoinositide turnover, and inositol
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Figure 6. [3H]myo-inositol incorporation into phosphoinositides of
aortic segments in vivo. Four chronically instrumented virgin and
pregnant rats were administered [3H]myo-inositol intravenously (50
GCi/275 g and 43 uCi/275 g body weight, respectively). Two-factor
ANOVA revealed no significant difference in plasma radioactivity
between virgin and gravid animals (A). 2 h after administration of
[3H]myo-inositol, the animals were killed, the aortae removed, and
analyzed for labeling of phosphoinositides (see Methods). (B) [3H]myo-
inositol labeling oflysophosphatidylinositol and phosphatidylinositol.
Significantly less incorporation of the label was observed in aortic
phosphoinositides of pregnant animals (unpaired t tests).
phosphate production in aortic vasculature ofrats during preg-
nancy. If these alterations also occur in resistance vessels, they
could contribute to vasodilation and/or attenuated pressor re-
sponsiveness of pregnancy. A unifying theory is that reduced
myo-inositol uptake is limiting intracellular availability of
myo-inositol for optimal synthesis ofphosphatidylinositol and,
consequently, ofpolyphosphoinositides. On this basis, both ba-
sal and hormone-stimulated turnover of phosphoinositides
and production of inositol phosphates could be compromised.
On the other hand, multiple defects may be operative, e.g.,
alteration of G-protein function, activity of phospholipase C,
or of other enzymes in the signal transduction pathway.
Clearly, further investigation is needed to clarify this issue, as
well as to identify the factor(s) responsible for initiating the
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Figure 7. [3H]myo-inositol uptake into aortic segments of virgin and
pregnant rats (n = 8 animals each). Tissues were preincubated for1
h in the presence (A) or absence (B) ofK+. The final concentration
of myo-inositol was 50 ,M. See Methods for details. Two-factor
ANOVA was performed in A; the P value given in the figure indicates
that overall, uptake of [3H]myo-inositol was significantly less in
aortic segments obtained from gravid rats, when compared with that
of virgin controls. The slopes of the lines were 0.27±0.03 and
0.19±0.01 for virgin and pregnant animals, respectively (P = 0.02).
In the absence of K+ (B), little or no uptake was detected in aortae
from either virgin or pregnant animals.
biochemical alterations observed in vasculature of pregnant
rats.
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